the absolute number of CD21+ cells (a marker for B-cells) was higher in the test group compared with the control group at week 8 of the test phase (difference 463, 95 % CI 188, 7380 cells/l
120 Sterol CoA desaturase (SCD1) is a lipid regulatory enzyme that catalyzes the desaturation of saturated fatty acids to their 9-monounsaturated counterparts
2014 Jan;37(2):419-27
indicated that GLP-1RAs treatment might increase the risk of thyroid cancer, with the risk demonstrating an upward trend with prolonged usage of the medication (13 years and longer) [4]
Their metabolic health markers, such as blood sugar and cholesterol, also returned to levels similar to those before treatment.(3) Another drawback to taking GLP-1 medications is that while they promote weight loss, recently published research shows that approximately 15% to 60% of the loss comes from lean mass.(5, 6) This is very concerning, because preserving muscle mass is crucial for maintaining metabolic rate, overall health, and functionality as we age.(7) The Potential Solution: A Ketogenic Lifestyle A paper by researchers at Virta Health, published in February 2024, suggests that a ketogenic diet may help people maintain their weight loss after transitioning off GLP-1 medications.(8) The study compared two groups of type 2 diabetes patients following a ketogenic diet: one group continued GLP-1 therapy, and the other group stopped the medication
Ipamorelin promotes GH release without spiking hunger or stress hormones, while BPC-157 is for recovery and inflammation control
